Leukemia Home > Sprycel Cardiac Toxicity

Sprycel® (dasatinib) is a medication prescribed to treat certain types of leukemia in adults. Although it can be an effective treatment for many people, there are some complications to be aware of with this medicine. For example, Sprycel can cause cardiac toxicity, which means this drug can cause damage to the heart.
Cardiac toxicity can lead to several complications, such as:
Your healthcare provider will monitor your heart function during Sprycel treatment, and treat you if necessary.
(For more information on how this drug can cause cardiac toxicity and other potentially serious complications, click Sprycel Warnings and Precautions. A list of who should not take this drug is also provided.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.